nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—CYP2C8—Mometasone—systemic scleroderma	0.192	0.309	CbGbCtD
Candesartan—ABCB1—Lisinopril—systemic scleroderma	0.088	0.141	CbGbCtD
Candesartan—CYP2C9—Leflunomide—systemic scleroderma	0.0865	0.139	CbGbCtD
Candesartan—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0766	0.123	CbGbCtD
Candesartan—ABCB1—Captopril—systemic scleroderma	0.0659	0.106	CbGbCtD
Candesartan—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0519	0.0832	CbGbCtD
Candesartan—ABCB1—Prednisone—systemic scleroderma	0.0415	0.0665	CbGbCtD
Candesartan—CYP2C9—cardial valve—systemic scleroderma	0.0258	0.313	CbGeAlD
Candesartan—ABCB1—Methotrexate—systemic scleroderma	0.0208	0.0334	CbGbCtD
Candesartan—AGTR1—artery—systemic scleroderma	0.00805	0.0974	CbGeAlD
Candesartan—AGTR1—endothelium—systemic scleroderma	0.0068	0.0822	CbGeAlD
Candesartan—AGTR1—blood vessel—systemic scleroderma	0.00627	0.0758	CbGeAlD
Candesartan—UGT1A3—digestive system—systemic scleroderma	0.00545	0.0659	CbGeAlD
Candesartan—PTGS1—artery—systemic scleroderma	0.00354	0.0428	CbGeAlD
Candesartan—AGTR1—connective tissue—systemic scleroderma	0.00321	0.0389	CbGeAlD
Candesartan—PTGS1—endothelium—systemic scleroderma	0.00299	0.0362	CbGeAlD
Candesartan—AGTR1—smooth muscle tissue—systemic scleroderma	0.00294	0.0356	CbGeAlD
Candesartan—PTGS1—blood vessel—systemic scleroderma	0.00276	0.0333	CbGeAlD
Candesartan—AGTR1—tendon—systemic scleroderma	0.00221	0.0267	CbGeAlD
Candesartan—AGTR1—lung—systemic scleroderma	0.00194	0.0235	CbGeAlD
Candesartan—ABCB1—blood vessel—systemic scleroderma	0.00163	0.0197	CbGeAlD
Candesartan—PTGS1—connective tissue—systemic scleroderma	0.00141	0.0171	CbGeAlD
Candesartan—PTGS1—smooth muscle tissue—systemic scleroderma	0.00129	0.0156	CbGeAlD
Candesartan—PTGS1—skin of body—systemic scleroderma	0.00128	0.0154	CbGeAlD
Candesartan—CYP2C9—digestive system—systemic scleroderma	0.00112	0.0135	CbGeAlD
Candesartan—PTGS1—digestive system—systemic scleroderma	0.00102	0.0123	CbGeAlD
Candesartan—PTGS1—tendon—systemic scleroderma	0.000971	0.0118	CbGeAlD
Candesartan—PTGS1—lung—systemic scleroderma	0.000852	0.0103	CbGeAlD
Candesartan—ABCB1—digestive system—systemic scleroderma	0.000603	0.0073	CbGeAlD
Candesartan—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00057	0.00194	CcSEcCtD
Candesartan—Arthralgia—Leflunomide—systemic scleroderma	0.000569	0.00194	CcSEcCtD
Candesartan—Chest pain—Leflunomide—systemic scleroderma	0.000569	0.00194	CcSEcCtD
Candesartan—Myalgia—Leflunomide—systemic scleroderma	0.000569	0.00194	CcSEcCtD
Candesartan—Anxiety—Leflunomide—systemic scleroderma	0.000567	0.00193	CcSEcCtD
Candesartan—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000567	0.00193	CcSEcCtD
Candesartan—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000566	0.00193	CcSEcCtD
Candesartan—Palpitations—Mycophenolic acid—systemic scleroderma	0.000564	0.00192	CcSEcCtD
Candesartan—Cough—Mycophenolic acid—systemic scleroderma	0.000557	0.0019	CcSEcCtD
Candesartan—Back pain—Lisinopril—systemic scleroderma	0.000556	0.00189	CcSEcCtD
Candesartan—Vomiting—Pentoxifylline—systemic scleroderma	0.000556	0.00189	CcSEcCtD
Candesartan—Rash—Pentoxifylline—systemic scleroderma	0.000551	0.00188	CcSEcCtD
Candesartan—Hypertension—Mycophenolic acid—systemic scleroderma	0.000551	0.00188	CcSEcCtD
Candesartan—Dermatitis—Pentoxifylline—systemic scleroderma	0.00055	0.00188	CcSEcCtD
Candesartan—Headache—Pentoxifylline—systemic scleroderma	0.000547	0.00187	CcSEcCtD
Candesartan—Myalgia—Mycophenolic acid—systemic scleroderma	0.000543	0.00185	CcSEcCtD
Candesartan—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000543	0.00185	CcSEcCtD
Candesartan—Chest pain—Mycophenolic acid—systemic scleroderma	0.000543	0.00185	CcSEcCtD
Candesartan—Gastrointestinal pain—Captopril—systemic scleroderma	0.000541	0.00185	CcSEcCtD
Candesartan—Anxiety—Mycophenolic acid—systemic scleroderma	0.000541	0.00184	CcSEcCtD
Candesartan—Asthenia—Mometasone—systemic scleroderma	0.000541	0.00184	CcSEcCtD
Candesartan—Hypotension—Azathioprine—systemic scleroderma	0.00054	0.00184	CcSEcCtD
Candesartan—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000534	0.00182	CcSEcCtD
Candesartan—Pruritus—Mometasone—systemic scleroderma	0.000533	0.00182	CcSEcCtD
Candesartan—Tachycardia—Leflunomide—systemic scleroderma	0.000533	0.00182	CcSEcCtD
Candesartan—Anaemia—Lisinopril—systemic scleroderma	0.000531	0.00181	CcSEcCtD
Candesartan—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000528	0.0018	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000526	0.00179	CcSEcCtD
Candesartan—Angioedema—Lisinopril—systemic scleroderma	0.000525	0.00179	CcSEcCtD
Candesartan—Body temperature increased—Captopril—systemic scleroderma	0.000523	0.00178	CcSEcCtD
Candesartan—Abdominal pain—Captopril—systemic scleroderma	0.000523	0.00178	CcSEcCtD
Candesartan—Nausea—Pentoxifylline—systemic scleroderma	0.000519	0.00177	CcSEcCtD
Candesartan—Vertigo—Lisinopril—systemic scleroderma	0.000516	0.00176	CcSEcCtD
Candesartan—Diarrhoea—Mometasone—systemic scleroderma	0.000516	0.00176	CcSEcCtD
Candesartan—Leukopenia—Lisinopril—systemic scleroderma	0.000514	0.00175	CcSEcCtD
Candesartan—Hypotension—Leflunomide—systemic scleroderma	0.00051	0.00174	CcSEcCtD
Candesartan—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00051	0.00174	CcSEcCtD
Candesartan—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000508	0.00173	CcSEcCtD
Candesartan—Palpitations—Lisinopril—systemic scleroderma	0.000508	0.00173	CcSEcCtD
Candesartan—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00173	CcSEcCtD
Candesartan—ABCB1—lung—systemic scleroderma	0.000504	0.0061	CbGeAlD
Candesartan—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000503	0.00172	CcSEcCtD
Candesartan—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000503	0.00172	CcSEcCtD
Candesartan—Cough—Lisinopril—systemic scleroderma	0.000501	0.00171	CcSEcCtD
Candesartan—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000499	0.0017	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000497	0.00169	CcSEcCtD
Candesartan—Paraesthesia—Leflunomide—systemic scleroderma	0.00049	0.00167	CcSEcCtD
Candesartan—Chest pain—Lisinopril—systemic scleroderma	0.000489	0.00167	CcSEcCtD
Candesartan—Arthralgia—Lisinopril—systemic scleroderma	0.000489	0.00167	CcSEcCtD
Candesartan—Myalgia—Lisinopril—systemic scleroderma	0.000489	0.00167	CcSEcCtD
Candesartan—Anxiety—Lisinopril—systemic scleroderma	0.000487	0.00166	CcSEcCtD
Candesartan—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000487	0.00166	CcSEcCtD
Candesartan—Dyspnoea—Leflunomide—systemic scleroderma	0.000487	0.00166	CcSEcCtD
Candesartan—Hypotension—Mycophenolic acid—systemic scleroderma	0.000486	0.00166	CcSEcCtD
Candesartan—Dyspepsia—Leflunomide—systemic scleroderma	0.00048	0.00164	CcSEcCtD
Candesartan—Vomiting—Mometasone—systemic scleroderma	0.000479	0.00163	CcSEcCtD
Candesartan—Sweating increased—Prednisone—systemic scleroderma	0.000477	0.00163	CcSEcCtD
Candesartan—Rash—Mometasone—systemic scleroderma	0.000475	0.00162	CcSEcCtD
Candesartan—Asthenia—Captopril—systemic scleroderma	0.000475	0.00162	CcSEcCtD
Candesartan—Dermatitis—Mometasone—systemic scleroderma	0.000475	0.00162	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000474	0.00162	CcSEcCtD
Candesartan—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000473	0.00161	CcSEcCtD
Candesartan—Headache—Mometasone—systemic scleroderma	0.000472	0.00161	CcSEcCtD
Candesartan—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000471	0.00161	CcSEcCtD
Candesartan—Fatigue—Leflunomide—systemic scleroderma	0.000471	0.0016	CcSEcCtD
Candesartan—Pruritus—Captopril—systemic scleroderma	0.000468	0.0016	CcSEcCtD
Candesartan—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000467	0.00159	CcSEcCtD
Candesartan—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00159	CcSEcCtD
Candesartan—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000464	0.00158	CcSEcCtD
Candesartan—Somnolence—Mycophenolic acid—systemic scleroderma	0.000463	0.00158	CcSEcCtD
Candesartan—Losartan—ACE—systemic scleroderma	0.000462	1	CrCbGaD
Candesartan—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00046	0.00157	CcSEcCtD
Candesartan—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000459	0.00156	CcSEcCtD
Candesartan—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000458	0.00156	CcSEcCtD
Candesartan—Neutropenia—Prednisone—systemic scleroderma	0.000458	0.00156	CcSEcCtD
Candesartan—Tachycardia—Lisinopril—systemic scleroderma	0.000458	0.00156	CcSEcCtD
Candesartan—Abdominal pain—Azathioprine—systemic scleroderma	0.000457	0.00156	CcSEcCtD
Candesartan—Body temperature increased—Azathioprine—systemic scleroderma	0.000457	0.00156	CcSEcCtD
Candesartan—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000453	0.00154	CcSEcCtD
Candesartan—Diarrhoea—Captopril—systemic scleroderma	0.000453	0.00154	CcSEcCtD
Candesartan—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000452	0.00154	CcSEcCtD
Candesartan—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000451	0.00154	CcSEcCtD
Candesartan—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000449	0.00153	CcSEcCtD
Candesartan—Fatigue—Mycophenolic acid—systemic scleroderma	0.000449	0.00153	CcSEcCtD
Candesartan—Nausea—Mometasone—systemic scleroderma	0.000448	0.00153	CcSEcCtD
Candesartan—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000446	0.00152	CcSEcCtD
Candesartan—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000445	0.00152	CcSEcCtD
Candesartan—Hyperglycaemia—Prednisone—systemic scleroderma	0.000442	0.00151	CcSEcCtD
Candesartan—Cough—Mycophenolate mofetil—systemic scleroderma	0.000439	0.0015	CcSEcCtD
Candesartan—Hypotension—Lisinopril—systemic scleroderma	0.000438	0.00149	CcSEcCtD
Candesartan—Dizziness—Captopril—systemic scleroderma	0.000438	0.00149	CcSEcCtD
Candesartan—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000435	0.00148	CcSEcCtD
Candesartan—Urticaria—Leflunomide—systemic scleroderma	0.000434	0.00148	CcSEcCtD
Candesartan—Abdominal pain—Leflunomide—systemic scleroderma	0.000431	0.00147	CcSEcCtD
Candesartan—Body temperature increased—Leflunomide—systemic scleroderma	0.000431	0.00147	CcSEcCtD
Candesartan—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00043	0.00147	CcSEcCtD
Candesartan—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00146	CcSEcCtD
Candesartan—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00146	CcSEcCtD
Candesartan—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00146	CcSEcCtD
Candesartan—Myocardial infarction—Prednisone—systemic scleroderma	0.000428	0.00146	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000427	0.00146	CcSEcCtD
Candesartan—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000427	0.00146	CcSEcCtD
Candesartan—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000426	0.00145	CcSEcCtD
Candesartan—Paraesthesia—Lisinopril—systemic scleroderma	0.000421	0.00143	CcSEcCtD
Candesartan—Vomiting—Captopril—systemic scleroderma	0.000421	0.00143	CcSEcCtD
Candesartan—Dyspnoea—Lisinopril—systemic scleroderma	0.000418	0.00142	CcSEcCtD
Candesartan—Rash—Captopril—systemic scleroderma	0.000417	0.00142	CcSEcCtD
Candesartan—Dermatitis—Captopril—systemic scleroderma	0.000417	0.00142	CcSEcCtD
Candesartan—Somnolence—Lisinopril—systemic scleroderma	0.000417	0.00142	CcSEcCtD
Candesartan—Headache—Captopril—systemic scleroderma	0.000415	0.00141	CcSEcCtD
Candesartan—Dyspepsia—Lisinopril—systemic scleroderma	0.000413	0.00141	CcSEcCtD
Candesartan—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000412	0.0014	CcSEcCtD
Candesartan—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000412	0.0014	CcSEcCtD
Candesartan—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000405	0.00138	CcSEcCtD
Candesartan—Fatigue—Lisinopril—systemic scleroderma	0.000404	0.00138	CcSEcCtD
Candesartan—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000402	0.00137	CcSEcCtD
Candesartan—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000401	0.00137	CcSEcCtD
Candesartan—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000397	0.00135	CcSEcCtD
Candesartan—Diarrhoea—Azathioprine—systemic scleroderma	0.000395	0.00135	CcSEcCtD
Candesartan—Haemoglobin—Prednisone—systemic scleroderma	0.000394	0.00134	CcSEcCtD
Candesartan—Nausea—Captopril—systemic scleroderma	0.000393	0.00134	CcSEcCtD
Candesartan—Haemorrhage—Prednisone—systemic scleroderma	0.000392	0.00134	CcSEcCtD
Candesartan—Asthenia—Leflunomide—systemic scleroderma	0.000392	0.00133	CcSEcCtD
Candesartan—Pruritus—Leflunomide—systemic scleroderma	0.000386	0.00132	CcSEcCtD
Candesartan—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000384	0.00131	CcSEcCtD
Candesartan—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000383	0.00131	CcSEcCtD
Candesartan—Neutropenia—Methotrexate—systemic scleroderma	0.000383	0.0013	CcSEcCtD
Candesartan—Dizziness—Azathioprine—systemic scleroderma	0.000382	0.0013	CcSEcCtD
Candesartan—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00038	0.0013	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000374	0.00128	CcSEcCtD
Candesartan—Asthenia—Mycophenolic acid—systemic scleroderma	0.000374	0.00127	CcSEcCtD
Candesartan—Diarrhoea—Leflunomide—systemic scleroderma	0.000373	0.00127	CcSEcCtD
Candesartan—Urticaria—Lisinopril—systemic scleroderma	0.000373	0.00127	CcSEcCtD
Candesartan—Body temperature increased—Lisinopril—systemic scleroderma	0.000371	0.00126	CcSEcCtD
Candesartan—Abdominal pain—Lisinopril—systemic scleroderma	0.000371	0.00126	CcSEcCtD
Candesartan—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000369	0.00126	CcSEcCtD
Candesartan—Pruritus—Mycophenolic acid—systemic scleroderma	0.000368	0.00126	CcSEcCtD
Candesartan—Vomiting—Azathioprine—systemic scleroderma	0.000367	0.00125	CcSEcCtD
Candesartan—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000366	0.00125	CcSEcCtD
Candesartan—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000365	0.00124	CcSEcCtD
Candesartan—Rash—Azathioprine—systemic scleroderma	0.000364	0.00124	CcSEcCtD
Candesartan—Dermatitis—Azathioprine—systemic scleroderma	0.000364	0.00124	CcSEcCtD
Candesartan—Headache—Azathioprine—systemic scleroderma	0.000362	0.00123	CcSEcCtD
Candesartan—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000362	0.00123	CcSEcCtD
Candesartan—Dizziness—Leflunomide—systemic scleroderma	0.000361	0.00123	CcSEcCtD
Candesartan—Renal failure—Methotrexate—systemic scleroderma	0.000359	0.00122	CcSEcCtD
Candesartan—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000356	0.00121	CcSEcCtD
Candesartan—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000355	0.00121	CcSEcCtD
Candesartan—Haematuria—Methotrexate—systemic scleroderma	0.000348	0.00119	CcSEcCtD
Candesartan—Vomiting—Leflunomide—systemic scleroderma	0.000347	0.00118	CcSEcCtD
Candesartan—Dizziness—Mycophenolic acid—systemic scleroderma	0.000344	0.00117	CcSEcCtD
Candesartan—Epistaxis—Methotrexate—systemic scleroderma	0.000344	0.00117	CcSEcCtD
Candesartan—Rash—Leflunomide—systemic scleroderma	0.000344	0.00117	CcSEcCtD
Candesartan—Dermatitis—Leflunomide—systemic scleroderma	0.000344	0.00117	CcSEcCtD
Candesartan—Mental disorder—Prednisone—systemic scleroderma	0.000343	0.00117	CcSEcCtD
Candesartan—Nausea—Azathioprine—systemic scleroderma	0.000343	0.00117	CcSEcCtD
Candesartan—Headache—Leflunomide—systemic scleroderma	0.000342	0.00117	CcSEcCtD
Candesartan—Malnutrition—Prednisone—systemic scleroderma	0.000341	0.00116	CcSEcCtD
Candesartan—Agranulocytosis—Methotrexate—systemic scleroderma	0.000341	0.00116	CcSEcCtD
Candesartan—Asthenia—Lisinopril—systemic scleroderma	0.000336	0.00115	CcSEcCtD
Candesartan—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000336	0.00114	CcSEcCtD
Candesartan—Pruritus—Lisinopril—systemic scleroderma	0.000332	0.00113	CcSEcCtD
Candesartan—Vomiting—Mycophenolic acid—systemic scleroderma	0.000331	0.00113	CcSEcCtD
Candesartan—Haemoglobin—Methotrexate—systemic scleroderma	0.000329	0.00112	CcSEcCtD
Candesartan—Rash—Mycophenolic acid—systemic scleroderma	0.000328	0.00112	CcSEcCtD
Candesartan—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000328	0.00112	CcSEcCtD
Candesartan—Haemorrhage—Methotrexate—systemic scleroderma	0.000328	0.00112	CcSEcCtD
Candesartan—Hepatitis—Methotrexate—systemic scleroderma	0.000328	0.00112	CcSEcCtD
Candesartan—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000326	0.00111	CcSEcCtD
Candesartan—Headache—Mycophenolic acid—systemic scleroderma	0.000326	0.00111	CcSEcCtD
Candesartan—Pharyngitis—Methotrexate—systemic scleroderma	0.000325	0.00111	CcSEcCtD
Candesartan—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00111	CcSEcCtD
Candesartan—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00111	CcSEcCtD
Candesartan—Nausea—Leflunomide—systemic scleroderma	0.000324	0.0011	CcSEcCtD
Candesartan—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000324	0.0011	CcSEcCtD
Candesartan—Urethral disorder—Methotrexate—systemic scleroderma	0.000321	0.00109	CcSEcCtD
Candesartan—Diarrhoea—Lisinopril—systemic scleroderma	0.000321	0.00109	CcSEcCtD
Candesartan—Anaemia—Prednisone—systemic scleroderma	0.000315	0.00107	CcSEcCtD
Candesartan—Angioedema—Prednisone—systemic scleroderma	0.000312	0.00106	CcSEcCtD
Candesartan—Dizziness—Lisinopril—systemic scleroderma	0.00031	0.00106	CcSEcCtD
Candesartan—Nausea—Mycophenolic acid—systemic scleroderma	0.000309	0.00105	CcSEcCtD
Candesartan—Vertigo—Prednisone—systemic scleroderma	0.000307	0.00104	CcSEcCtD
Candesartan—Vomiting—Lisinopril—systemic scleroderma	0.000298	0.00102	CcSEcCtD
Candesartan—Rash—Lisinopril—systemic scleroderma	0.000296	0.00101	CcSEcCtD
Candesartan—Dermatitis—Lisinopril—systemic scleroderma	0.000295	0.00101	CcSEcCtD
Candesartan—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000295	0.001	CcSEcCtD
Candesartan—Hypertension—Prednisone—systemic scleroderma	0.000295	0.001	CcSEcCtD
Candesartan—Headache—Lisinopril—systemic scleroderma	0.000294	0.001	CcSEcCtD
Candesartan—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000291	0.000991	CcSEcCtD
Candesartan—Myalgia—Prednisone—systemic scleroderma	0.000291	0.00099	CcSEcCtD
Candesartan—Arthralgia—Prednisone—systemic scleroderma	0.000291	0.00099	CcSEcCtD
Candesartan—Anxiety—Prednisone—systemic scleroderma	0.00029	0.000987	CcSEcCtD
Candesartan—Mental disorder—Methotrexate—systemic scleroderma	0.000287	0.000978	CcSEcCtD
Candesartan—Malnutrition—Methotrexate—systemic scleroderma	0.000285	0.000972	CcSEcCtD
Candesartan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000958	CcSEcCtD
Candesartan—Nausea—Lisinopril—systemic scleroderma	0.000279	0.000949	CcSEcCtD
Candesartan—Back pain—Methotrexate—systemic scleroderma	0.000276	0.00094	CcSEcCtD
Candesartan—Tachycardia—Prednisone—systemic scleroderma	0.000272	0.000926	CcSEcCtD
Candesartan—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000926	CcSEcCtD
Candesartan—Hyperhidrosis—Prednisone—systemic scleroderma	0.000269	0.000917	CcSEcCtD
Candesartan—Anaemia—Methotrexate—systemic scleroderma	0.000264	0.000898	CcSEcCtD
Candesartan—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000261	0.00089	CcSEcCtD
Candesartan—Rash—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000883	CcSEcCtD
Candesartan—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000882	CcSEcCtD
Candesartan—Headache—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000877	CcSEcCtD
Candesartan—Vertigo—Methotrexate—systemic scleroderma	0.000256	0.000873	CcSEcCtD
Candesartan—Leukopenia—Methotrexate—systemic scleroderma	0.000255	0.00087	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000254	0.000865	CcSEcCtD
Candesartan—Paraesthesia—Prednisone—systemic scleroderma	0.00025	0.000852	CcSEcCtD
Candesartan—Cough—Methotrexate—systemic scleroderma	0.000249	0.000848	CcSEcCtD
Candesartan—Dyspepsia—Prednisone—systemic scleroderma	0.000245	0.000835	CcSEcCtD
Candesartan—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000832	CcSEcCtD
Candesartan—Arthralgia—Methotrexate—systemic scleroderma	0.000243	0.000827	CcSEcCtD
Candesartan—Chest pain—Methotrexate—systemic scleroderma	0.000243	0.000827	CcSEcCtD
Candesartan—Myalgia—Methotrexate—systemic scleroderma	0.000243	0.000827	CcSEcCtD
Candesartan—Fatigue—Prednisone—systemic scleroderma	0.00024	0.000818	CcSEcCtD
Candesartan—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000228	0.000777	CcSEcCtD
Candesartan—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000228	0.000776	CcSEcCtD
Candesartan—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000225	0.000767	CcSEcCtD
Candesartan—Urticaria—Prednisone—systemic scleroderma	0.000221	0.000754	CcSEcCtD
Candesartan—Abdominal pain—Prednisone—systemic scleroderma	0.00022	0.00075	CcSEcCtD
Candesartan—Body temperature increased—Prednisone—systemic scleroderma	0.00022	0.00075	CcSEcCtD
Candesartan—Hypotension—Methotrexate—systemic scleroderma	0.000217	0.000741	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000212	0.000723	CcSEcCtD
Candesartan—Paraesthesia—Methotrexate—systemic scleroderma	0.000209	0.000712	CcSEcCtD
Candesartan—Dyspnoea—Methotrexate—systemic scleroderma	0.000208	0.000707	CcSEcCtD
Candesartan—Somnolence—Methotrexate—systemic scleroderma	0.000207	0.000705	CcSEcCtD
Candesartan—Dyspepsia—Methotrexate—systemic scleroderma	0.000205	0.000698	CcSEcCtD
Candesartan—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000201	0.000685	CcSEcCtD
Candesartan—Fatigue—Methotrexate—systemic scleroderma	0.000201	0.000684	CcSEcCtD
Candesartan—Asthenia—Prednisone—systemic scleroderma	0.0002	0.000681	CcSEcCtD
Candesartan—Pruritus—Prednisone—systemic scleroderma	0.000197	0.000671	CcSEcCtD
Candesartan—Diarrhoea—Prednisone—systemic scleroderma	0.000191	0.000649	CcSEcCtD
Candesartan—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00019	0.000649	CcSEcCtD
Candesartan—Urticaria—Methotrexate—systemic scleroderma	0.000185	0.00063	CcSEcCtD
Candesartan—Dizziness—Prednisone—systemic scleroderma	0.000184	0.000628	CcSEcCtD
Candesartan—Abdominal pain—Methotrexate—systemic scleroderma	0.000184	0.000627	CcSEcCtD
Candesartan—Body temperature increased—Methotrexate—systemic scleroderma	0.000184	0.000627	CcSEcCtD
Candesartan—Vomiting—Prednisone—systemic scleroderma	0.000177	0.000603	CcSEcCtD
Candesartan—Rash—Prednisone—systemic scleroderma	0.000176	0.000598	CcSEcCtD
Candesartan—Dermatitis—Prednisone—systemic scleroderma	0.000175	0.000598	CcSEcCtD
Candesartan—Headache—Prednisone—systemic scleroderma	0.000174	0.000595	CcSEcCtD
Candesartan—Asthenia—Methotrexate—systemic scleroderma	0.000167	0.000569	CcSEcCtD
Candesartan—Nausea—Prednisone—systemic scleroderma	0.000165	0.000564	CcSEcCtD
Candesartan—Pruritus—Methotrexate—systemic scleroderma	0.000165	0.000561	CcSEcCtD
Candesartan—Diarrhoea—Methotrexate—systemic scleroderma	0.000159	0.000543	CcSEcCtD
Candesartan—Dizziness—Methotrexate—systemic scleroderma	0.000154	0.000525	CcSEcCtD
Candesartan—Vomiting—Methotrexate—systemic scleroderma	0.000148	0.000504	CcSEcCtD
Candesartan—Rash—Methotrexate—systemic scleroderma	0.000147	0.0005	CcSEcCtD
Candesartan—Dermatitis—Methotrexate—systemic scleroderma	0.000147	0.0005	CcSEcCtD
Candesartan—Headache—Methotrexate—systemic scleroderma	0.000146	0.000497	CcSEcCtD
Candesartan—Nausea—Methotrexate—systemic scleroderma	0.000138	0.000471	CcSEcCtD
